文献速递系统性红斑狼疮

核输出小分子抑制剂通过调节浆细胞生成与存活改善狼疮

Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and Survival.
PubMed 文献 · Arthritis Rheumatol · 2022-06-28

在雌性NZB/NZW小鼠中,核输出选择性抑制剂KPT-350可消除早期和晚期狼疮性肾炎,并快速削弱生发中心自反应性浆细胞的生成。SINE化合物抑制基质细胞产生NF-κB驱动的稳态趋化因子,改变脾脏B细胞和T细胞定位,减少滤泡辅助性T细胞、生发中心B细胞及自反应性浆细胞数量;exportin 1在人类扁桃体生发中心、狼疮患者脾脏B细胞及狼疮性肾炎患者肾脏多种B细胞亚群中可检测到。

要点

  • KPT-350在NZB/NZW小鼠早期和晚期均消除狼疮性肾炎。
  • SINE化合物快速削弱生发中心自反应性浆细胞生成。
  • exportin 1在人类狼疮相关组织和肾脏B细胞亚群中可检测到。

核心结论

  • 结果支持SINE化合物通过靶向狼疮发病机制中多个关键分子和细胞通路(包括浆细胞产生自身抗体)具有治疗潜力。

研究设计与样本

  • 雌性NZB/NZW小鼠分别接受SINE化合物KPT-350或溶媒对照处理,取组织标本用标准标志物进行流式细胞术分析。

主要发现

  • KPT-350在疾病早期和晚期均消除小鼠狼疮性肾炎,并快速削弱生发中心自反应性浆细胞的生成。
  • SINE化合物抑制基质细胞产生NF-κB驱动的稳态趋化因子,改变脾脏B细胞和T细胞定位,显著减少滤泡辅助性T细胞、生发中心B细胞和自反应性浆细胞计数。
  • KPT-350还降低狼疮易感小鼠肾脏中参与浆细胞存活和募集的细胞因子和趋化因子水平。
  • exportin 1(SINE化合物的靶点)在人类扁桃体生发中心、狼疮患者脾脏B细胞及狼疮性肾炎患者肾脏多种B细胞亚群中可检测到。

关键数值与推荐

  • 肾炎通过蛋白尿评分和肾脏标本组织学分析监测。
  • 血清抗双链DNA(anti-dsDNA)水平用酶联免疫吸附试验测定,IgG分泌细胞和dsDNA特异性抗体分泌细胞总数用酶联免疫斑点试验评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the hypothesis that selective inhibitors of nuclear export (SINE compounds), recently approved for treatment of refractory plasma cell (PC) malignancy, may have potential in the treatment of lupus. METHODS: Female NZB/NZW mice were treated with the SINE compound KPT-350 or vehicle control. Tissue specimens were harvested and analyzed by flow cytometry, using standard markers. Nephritis was monitored by determining the proteinuria score and by histologic analysis of kidney specimens. Serum anti-double-stranded DNA (anti-dsDNA) levels were measured by enzyme-linked immunosorbent assay, and total numbers of IgG-secreting and dsDNA-specific antibody-secreting cells were assessed by enzyme-linked immunospot assay. RESULTS: KPT-350 abrogated murine lupus nephritis at both early and late stages of the disease and rapidly impaired generation of autoreactive PCs in germinal centers (GCs). SINE compounds inhibited the production of NF-κB-driven homeostatic chemokines by stromal cells, altering splenic B and T cell strategic positioning and significantly reducing follicular helper T cell, GC B cell, and autoreactive PC counts. KPT-350 also decreased levels of cytokines and chemokines involved in PC survival and recruitment in the kidney of lupus-prone mice. Exportin 1, the target of SINE compounds, was detected in GCs of human tonsils, splenic B cells of lupus patients, and multiple B cell subsets in the kidneys of patients with lupus nephritis. CONCLUSION: Collectively, our results provide support for the therapeutic potential of SINE compounds, via their targeting of several molecular and cellular pathways critical in lupus pathogenesis, including autoantibody production by plasma cells.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Rangel-Moreno J, Garcia-Hernandez ML, Owen T, et al. Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and Survival. Arthritis Rheumatol. 2022. PMID: 35333447. doi:10.1002/art.42128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。